UPDATE 1-FDA puts clinical hold on Advaxis cancer drug
October 06, 2015 at 17:00 PM EDT
Oct 6 (Reuters) - Advaxis Inc said the U.S. Food and Drug Administration has put on hold the mid-stage trials of its experimental cancer drug after a patient died, sending its shares down 27 percent in extended trading.